by evommune | Dec 5, 2023
Rob is a Managing Partner at Pivotal bioVenture Partners, where he focuses on drug discovery and development investments. He has a long track record of working successfully with entrepreneurs to progress novel, important medicines through development and onto the...
by evommune | Dec 5, 2023
Dr. David E. Cohen has held various positions at the New York University School of Medicine, including Charles C. and Dorothea E. Harris Professor of Dermatology, Vice Chairman of Clinical Affairs, Chief of Allergy and Contact Dermatitis, and Director of Occupational...
by evommune | Dec 5, 2023
Dr. Eugene A. Bauer is Chief Medical Officer and a member of the Board of Directors of Evommune. From 2010 to 2020, Gene was Founder, Chief Medical Officer, and member of the Board of Directors of Dermira, a clinical stage dermatology company acquired by Eli Lilly and...
by evommune | Dec 5, 2023
Luis Peña is Founder, President & Chief Executive Officer and a member of the Board of Directors of Evommune. Luis has more than 30 years of biotech and pharmaceutical experience with a proven track record of success in the global development of diverse products...
